फ्लुटिकासोन और सैल्मेटेरोल और मिथाइलफेनिडेट का इंटरैक्शन

Clinically significant cardiovascular effects and fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs.

Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs.

Therefore, Fluticasone Propionate/Salmeterol MDPI, like all products containing sympathomimetic amines, should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, cardiac arrhythmias, and hypertension.

Coexisting Conditions Fluticasone Propionate/Salmeterol MDPI, like all medicines containing sympathomimetic amines, should be used with caution in patients with convulsive disorders or thyrotoxicosis and in those who are unusually responsive to sympathomimetic amines.